Trade Mark Journal No.2026/014 3 April 2026

UK00004358429 20 March 2026 (5)

XCELVA

Class 5
Pharmaceutical and medicinal preparations and substances; vaccines.

GlaxoSmithKline Biologicals S.A.

Representative: Legal Brand Protection, GSK